doxapram has been researched along with Dyskinesia, Medication-Induced in 2 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Excerpt | Relevance | Reference |
---|---|---|
"Doxapram is a respiratory stimulating drug that affects both peripheral chemoreceptors and medullary respiratory and nonrespiratory neurons." | 5.26 | Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome. ( Hunt, CE; Inwood, RJ; Shannon, DC, 1979) |
"Doxapram is a respiratory stimulating drug that affects both peripheral chemoreceptors and medullary respiratory and nonrespiratory neurons." | 1.26 | Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome. ( Hunt, CE; Inwood, RJ; Shannon, DC, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dear, PR | 1 |
Wheeler, D | 1 |
Hunt, CE | 1 |
Inwood, RJ | 1 |
Shannon, DC | 1 |
2 other studies available for doxapram and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Doxapram and neonatal apnoea.
Topics: Apnea; Doxapram; Dyskinesia, Drug-Induced; Humans; Infant, Newborn | 1984 |
Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome.
Topics: Chemical and Drug Induced Liver Injury; Doxapram; Duodenal Ulcer; Dyskinesia, Drug-Induced; Humans; | 1979 |